Fred Andy Broadway III

2019

In 2019, Fred Andy Broadway III earned a total compensation of $1.1M as President, BioTel Heart at BioTelemetry, a 5% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$147,190
Option Awards$208,466
Salary$356,411
Stock Awards$322,490
Other$21,034
Total$1,055,591

Broadway received $356.4K in salary, accounting for 34% of the total pay in 2019.

Broadway also received $147.2K in non-equity incentive plan, $208.5K in option awards, $322.5K in stock awards and $21K in other compensation.

Rankings

In 2019, Fred Andy Broadway III's compensation ranked 9,043rd out of 13,971 executives tracked by ExecPay. In other words, Broadway earned more than 35.3% of executives.

ClassificationRankingPercentile
All
9,043
out of 13,971
35th
Division
Services
1,663
out of 2,389
30th
Major group
Health Services
153
out of 237
35th
Industry group
Miscellaneous Health And Allied Services, Not
29
out of 47
38th
Industry
Specialty Outpatient Facilities, Not Elsewhere Classified
8
out of 15
47th
Source: SEC filing on March 23, 2020.

Broadway's colleagues

We found four more compensation records of executives who worked with Fred Andy Broadway III at BioTelemetry in 2019.

2019

Joseph Capper

BioTelemetry

Chief Executive Officer

2019

Heather Getz

BioTelemetry

Executive Vice President, Chief Financial and Administrative Officer

2019

Daniel Wisniewski

BioTelemetry

Senior Vice President, Technical Operations

2019

Peter Ferola

BioTelemetry

General Counsel

News

You may also like